David S Liebeskind Selected Research

Thrombectomy

12/2022	Aspiration thrombectomy using a novel 088 catheter and specialized delivery catheter.
8/2022	Embotrap Extraction & Clot Evaluation & Lesion Evaluation for NeuroThrombectomy (EXCELLENT) Registry design and methods.
6/2022	Mechanical thrombectomy with a novel device: initial clinical experience with the ANA thrombectomy device.
6/2022	Heterogeneity between proximal and distal aspects of occlusive thrombi on pretreatment imaging in acute ischemic stroke.
4/2022	A mobile battery-powered brain perfusion ultrasound (BPU) device designed for prehospital stroke diagnosis: correlation to perfusion MRI in healthy volunteers.
3/2022	Influence of time to endovascular stroke treatment on outcomes in the early versus extended window paradigms.
1/2022	Clinical Results of the Advanced Neurovascular Access Catheter System Combined With a Stent Retriever in Acute Ischemic Stroke (SOLONDA).
1/2022	Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.
1/2022	Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial.
1/2022	First Pass Effect With Neurothrombectomy for Acute Ischemic Stroke: Analysis of the Systematic Evaluation of Patients Treated With Stroke Devices for Acute Ischemic Stroke Registry.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David S Liebeskind Research Topics

Disease

210	Stroke (Strokes) 12/2022 - 01/2003
146	Ischemic Stroke 06/2022 - 01/2002
34	Infarction (Infarctions) 03/2022 - 09/2007
23	Pathologic Constriction (Stenosis) 01/2022 - 05/2010
17	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2022 - 10/2007
17	Brain Ischemia (Cerebral Ischemia) 01/2022 - 03/2004
14	Cerebral Infarction 01/2022 - 04/2002
13	Ischemia 10/2021 - 02/2008
11	Hemorrhage 01/2022 - 04/2007
10	Hypertension (High Blood Pressure) 01/2021 - 05/2007
10	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2018 - 12/2002
8	Thrombosis (Thrombus) 08/2022 - 03/2012
8	COVID-19 02/2022 - 01/2020
7	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 08/2018 - 01/2012
7	Cerebrovascular Disorders (Cerebrovascular Occlusion) 05/2017 - 10/2009
6	Hematoma 01/2022 - 02/2012
6	Cerebral Hemorrhage 11/2019 - 01/2002
6	Atrial Fibrillation 01/2019 - 01/2006
5	Embolism (Embolus) 02/2021 - 12/2009
5	Neurologic Manifestations (Neurological Manifestations) 11/2020 - 01/2008
5	Transient Ischemic Attack 05/2017 - 08/2006
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017 - 09/2010
5	Hyperlipidemias (Hyperlipidemia) 10/2016 - 01/2009
4	Embolic Stroke 01/2021 - 01/2013
4	Atherosclerosis 08/2018 - 01/2008
3	Heart Failure 01/2021 - 11/2016
3	Inflammation (Inflammations) 01/2020 - 01/2017
3	Diabetes Mellitus 10/2016 - 05/2007
2	Edema (Dropsy) 01/2022 - 11/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022 - 09/2014
2	Thrombophilia 01/2021 - 01/2014
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 12/2010
2	Reperfusion Injury 01/2021 - 09/2013
2	Brain Injuries (Brain Injury) 12/2017 - 01/2015
2	Myocardial Infarction 09/2013 - 06/2011
1	Hemorrhagic Stroke 01/2022
1	Brain Infarction 01/2022
1	Brain Edema (Cerebral Edema) 11/2021
1	Endocarditis 06/2021

Drug/Important Bio-Agent (IBA)

23	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022 - 10/2007
17	MagnesiumIBA 01/2022 - 01/2009
13	Biomarkers (Surrogate Marker)IBA 02/2021 - 05/2008
12	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 05/2007
11	Phenobarbital (Luminal)FDA Link 01/2022 - 05/2010
8	Cytidine Triphosphate (CTP)IBA 03/2022 - 02/2016
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 08/2006
6	AnticoagulantsIBA 01/2022 - 10/2016
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2005
5	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2022 - 02/2014
5	Blood Glucose (Blood Sugar)IBA 01/2022 - 06/2011
5	Warfarin (Coumadin)FDA LinkGeneric 01/2022 - 06/2011
4	Fibrinolytic Agents (Antithrombotic Agents)IBA 10/2016 - 04/2002
3	Neuroprotective AgentsIBA 01/2022 - 02/2014
3	CholesterolIBA 01/2022 - 08/2006
3	oxidized low density lipoproteinIBA 01/2022 - 01/2015
3	LipidsIBA 01/2022 - 01/2014
3	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 07/2018
3	antineoplaston A10 (A 10)IBA 01/2021 - 01/2012
3	Antihypertensive Agents (Antihypertensives)IBA 01/2019 - 01/2006
3	Indicators and Reagents (Reagents)IBA 12/2018 - 02/2012
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2014 - 06/2011
2	Tenecteplase FDA Link 04/2022 - 10/2018
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 10/2009
2	Complement System Proteins (Complement)IBA 01/2021 - 09/2007
2	CytokinesIBA 01/2021 - 11/2008
2	Dihydrotachysterol (AT 10)IBA 10/2020 - 12/2015
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2014
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020 - 01/2008
2	Vitamin K FDA Link 01/2017 - 01/2017
2	Pharmaceutical PreparationsIBA 02/2015 - 06/2013
2	HomocysteineIBA 01/2010 - 10/2009
2	ElementsIBA 02/2008 - 08/2006
1	LDL CholesterolIBA 01/2022
1	PlatinumIBA 01/2022
1	HDL CholesterolIBA 01/2022
1	Dabigatran FDA Link 01/2022
1	MetalsIBA 01/2022
1	trans-sodium crocetinate (crocetin)IBA 01/2022
1	C-Reactive ProteinIBA 12/2021
1	PlasminogenIBA 06/2021
1	cyclo(Arg-Pro) (CI 4)IBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021

Therapy/Procedure

154	Therapeutics 06/2022 - 12/2002
94	Thrombectomy 12/2022 - 04/2007
18	Stents 01/2022 - 06/2011
13	Precision Medicine 11/2021 - 01/2014
8	Punctures 01/2022 - 09/2013
8	Thrombolytic Therapy 12/2021 - 01/2002
7	Catheters 01/2022 - 08/2008
4	Time-to-Treatment 03/2022 - 11/2011
4	Treatment Delay 02/2022 - 01/2015
4	General Anesthesia 01/2020 - 06/2010
4	Embolectomy 01/2017 - 01/2009
3	Length of Stay 01/2021 - 03/2007
3	Secondary Prevention 05/2017 - 08/2006
3	Endovascular Procedures 01/2015 - 01/2009
2	Aftercare (After-Treatment) 01/2019 - 08/2014
1	Hospice Care (Care, Bereavement) 02/2022
1	Transcranial Direct Current Stimulation 01/2022
1	Drug-Eluting Stents 01/2022